The Next

Lean is a business philosophy and company-wide culture that alleviates the challenges and constraints facing today’s design and construction industry.

What do the contents of Fido’s dish and the output of a modern food research lab have in common? Plenty, if you ask innovators with their eye on the next big opportunity in pet food manufacturing.

Resource reduction measures are solutions that can lead to lifecycle energy and cost savings for a favorable return on investment while simultaneously improving resiliency and promoting health and wellness in your facility.

How legacy dairy facilities can meet the challenge of modernization. 

Increasingly, manufacturers want standard facility designs of their GMP manufacturing facilities so they can be replicated elsewhere in the world, but this approach comes with unique considerations.

Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.

Scaling up cultured meat to achieve commercial viability will require addressing three major challenges.

Changing the way therapies work, and the changing work of making therapies.

To bring the exciting science of cell and gene therapy manufacturing to life, creating smaller-scale filling solutions is imperative to the success of the ATMP industry. But before you begin scaling your operation, there are important questions to consider about fill-finish in ATMP.

If one word could summarize the nature of capital project delivery right now, it would be more. More complexity, more speed, more unpredictability. More pressure. Above all: more data analytics.